Clinical Trial Update: A Study of Mircera in Hemoglobin Control of Patients Transitioning to Dialysis. [Phase 3]

View source ↗

Summary

A Phase 3 trial evaluating Mircera for hemoglobin control in patients transitioning to dialysis was terminated, with results posted on 2011-12-16.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Anemia
• Chronic Kidney Disease
• End-stage Renal Disease

Drugs mentioned

• MIRCERA (METHOXY POLYETHYLENE GLYCOL-EPOETIN BETA)

Snippet

Sponsor: Hoffmann-La Roche | Conditions: Anemia | Phase 3 | Status: TERMINATED | Results posted: 2011-12-16